Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Clinical trial NCT01731249 · COMPLETED

Trial details

NCT number: NCT01731249
Sponsor: Stallergenes Greer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypersensitivity Allergic Rhinitis Allergic Conjunctivitis Seasonal Allergy

Start date: 2010-11-01
Primary completion: 2012-07-01
Enrollment: 574

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.